Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F8YKV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,056
Award facts
- Contract value 100% obligated
- $7,056.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,056.04 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026.
Repatha is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patients. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems, the Defense Health Agency, and other federal health programs globally. The company's extensive portfolio with DLA demonstrates consistent capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging from minimal to substantial values across multiple therapeutic domains including specialty medications, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DR26F8YKV?
SPE2DR26F8YKV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26F8YKV worth?
The government has obligated $7,056 on SPE2DR26F8YKV.
Is contract SPE2DR26F8YKV an order under another contract?
Yes. SPE2DR26F8YKV is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YKV competed?
The extent of competition for SPE2DR26F8YKV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award